Carfilzomib Consolidation Therapy After Autologous Stem Cell Transplantation (ASCT) for Mantle Cell Lymphoma (MCL), T-cell Lymphoma (TCL), and Diffuse Large B-Cell Lymphoma (DLBCL)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Carfilzomib
Related studies linked through entity extraction aliases.
S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Weekly Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients (wCCyd)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531
- Status
- COMPLETED
- Phase
- PHASE2
Carfilzomib and Dexamethasone in Treating Patients With Multiple Myeloma Who Previously Underwent a Stem Cell Transplant
- Status
- WITHDRAWN
- Phase
- PHASE2
A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain Amyloidosis
- Status
- COMPLETED
- Phase
- PHASE1
Carfilzomib in Refractory Renal Cell Carcinoma (RCC)
- Status
- COMPLETED
- Phase
- PHASE2
Study of High Dose Carfilzomib in Multiple Myeloma Patients Who Have Progressed On Standard Dose Carfilzomib
- Status
- COMPLETED
- Phase
- PHASE2
Dose-Escalation Trial of Carfilzomib With and Without Romidepsin in Cutaneous T-Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Carfilzomib + High Dose Melphalan as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Safety Study of Carfilzomib, Cyclophosphamide & Dexamethasone Prior to ASCT in Patients With Newly Diagnosed Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2